(NEW YORK)Ireland-based Icon PLC, which provides outsourced development services to drug and medical device makers, said Tuesday it will manage drug developer Eli Lilly & Co.'s clinical data...READ MORE

(NEW YORK)Tighter spending within the drug development industry and a decline in foreign exchange benefits likely will weaken revenue expectations throughout the outsourced clinical research...READ MORE

(PRINCETON, N.J.)Drug development services company Covance Inc. said Wednesday its third-quarter profit rose 15 percent on higher revenue from early- and late-stage development programs.READ MORE

(NEW YORK)Drug development services company Covance Inc. said Friday it closed a 10-year, $1.6 billion research agreement with drugmaker Eli Lilly & Co. Princeton, N.J.-based Covance will ga...READ MORE

(PRINCETON, N.J.)Covance Inc. and WuXi Pharmatech announced Monday they are abandoning plans to build a joint venture for preclinical contract research services in China.READ MORE

(WASHINGTON)Federal antitrust regulators on Tuesday cleared Eli Lilly & Co.'s $50 million sale of a research facility to drug development services provider Covance Inc.READ MORE

Among the sector activity stories for Wednesday, Aug. 6, from AP Financial News: NEW YORK (AP)--Shares of refiners soared Wednesday as crude prices continued their downward march o...READ MORE